GLANZMANN THROMBASTHENIA
Clinical trials for GLANZMANN THROMBASTHENIA explained in plain language.
Never miss a new study
Get alerted when new GLANZMANN THROMBASTHENIA trials appear
Sign up with your email to follow new studies for GLANZMANN THROMBASTHENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare bleeding disorder: drug shows promise in small trial
Disease control Recruiting nowThis study tests an investigational drug called eptacog beta for people with Glanzmann Thrombasthenia, a rare inherited bleeding disorder. Over 9 months, 6 participants will use the drug to treat serious bleeding episodes, and some may choose an extra 6-month phase to prevent ble…
Matched conditions: GLANZMANN THROMBASTHENIA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Scientists seek clues to rare bleeding disorders in blood cell study
Knowledge-focused Recruiting nowThis study aims to learn more about how blood cells work together and what goes wrong in inherited bleeding disorders like Glanzmann thrombasthenia. Researchers will study blood samples from up to 60 healthy volunteers and patients with certain blood or clotting disorders. The go…
Matched conditions: GLANZMANN THROMBASTHENIA
Sponsor: Rockefeller University • Aim: Knowledge-focused
Last updated May 11, 2026 20:48 UTC
-
Massive blood disorder registry launches to transform care
Knowledge-focused Recruiting nowThis study is creating a huge database of health information from up to 200,000 people with blood disorders like hemophilia, sickle cell disease, and thrombosis. Researchers will use this data to better understand these conditions and improve treatments. Anyone seen at a particip…
Matched conditions: GLANZMANN THROMBASTHENIA
Sponsor: American Thrombosis and Hemostasis Network • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC